Investigators record adverse events in the Electronic Data Capture (EDC) system, where they are encoded using MedDRA Preferred Terms (PTs) to determine frequency and safety signals.
A serious adverse event (SAE) — resulting in death, hospitalization, disability, or life-threatening conditions — requires expedited regulatory reporting to the FDA under IND safety rules.